| Announce Date | 12/17/2025 |
| EPS Normalized Actual | $4.78 (Beat by $0.82) |
| EPS GAAP Actual | $4.78 (Beat by $0.82) |
| Revenue Actual | $13.643B |
| Revenue Surprise | Beat by $13643M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Aug 2030 | 0 | INF | 0 | 0 | 4 |
| Aug 2030 | 0 | INF | 0 | 0 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 4.66 | 4.66 | 13.643B | 36.17% | 13643M |
| FQ3 2025 (Aug 2025) | 2.86 | 2.86 | 11.315B | 31.51% | 11315M |
| FQ2 2025 (May 2025) | 1.69 | 1.69 | 9.301B | 26.77% | 9301M |
| FQ1 2025 (Feb 2025) | -1.68 | -1.68 | 8.053B | 27.68% | 8053M |
| FQ4 2024 (Nov 2024) | 1.68 | 1.68 | 8.709B | 45.73% | 8709M |
| FQ3 2024 (Aug 2024) | 0.8 | 0.8 | 7.75B | 48.26% | 7750M |
| FQ2 2024 (May 2024) | 0.3 | 0.3 | 6.811B | 44.91% | 6811M |
| FQ1 2024 (Feb 2024) | 0.72 | 0.72 | 5.824B | 36.59% | 5824M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 5.78455 | -- | 5.49406 | 6.13027 | 7 |
| FQ2 2028 (May 2028) | 8.99528 | -- | 7.91844 | 9.95597 | 15 |
| FQ1 2028 (Feb 2028) | 8.95679 | -- | 7.88456 | 9.91337 | 8 |
| FQ4 2027 (Nov 2027) | 3.19 | -- | 2.67602 | 3.3916 | 18 |
| FQ3 2027 (Aug 2027) | 3.2174 | -- | 3.17597 | 3.24628 | 11 |
| FQ2 2027 (May 2027) | 3.21165 | -- | 3.1703 | 3.24048 | 11 |
| FQ1 2027 (Mar 2027) | 3.72956 | -- | 3.58014 | 3.88608 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 18.03B | -- | 17.34B | 18.86B | 11 |
| FQ2 2028 (May 2028) | 21.36B | -- | 19.39B | 23.11B | 6 |
| FQ1 2028 (Feb 2028) | 21.04B | -- | 19.1B | 22.77B | 6 |
| FQ4 2027 (Nov 2027) | 12.29B | -- | 10.77B | 12.89B | 11 |
| FQ3 2027 (Aug 2027) | 11.91B | -- | 11.79B | 11.99B | 18 |
| FQ2 2027 (May 2027) | 12.12B | -- | 12B | 12.2B | 12 |
| FQ1 2027 (Mar 2027) | 12.52B | -- | 12.13B | 12.92B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 4.66 | 4.66 | 100% | |
| FQ3 2025 (Aug 2025) | 2.86 | 2.86 | 100% | |
| FQ2 2025 (May 2025) | 1.69 | 1.69 | 100% | |
| FQ1 2025 (Feb 2025) | -1.68 | -1.68 | 100% | |
| FQ4 2024 (Nov 2024) | 1.68 | 1.68 | 100% | |
| FQ3 2024 (Aug 2024) | 0.8 | 0.8 | 100% | |
| FQ2 2024 (May 2024) | 0.3 | 0.3 | 100% | |
| FQ1 2024 (Feb 2024) | 0.72 | 0.72 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $13.64B | $13643M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $11.32B | $11315M | 100% |
| FQ2 2025 (May 2025) | $0B | $9.3B | $9301M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $8.05B | $8053M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $8.71B | $8709M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $7.75B | $7750M | 100% |
| FQ2 2024 (May 2024) | $0B | $6.81B | $6811M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $5.82B | $5824M | 100% |